filmov
tv
AML: Optimizing Selection and Use of Venetoclax + Azacitidine
Показать описание
In the setting of acute myeloid leukemia, experts consider where best to use the combination of venetoclax + azacitidine over other regimens.
Targeted Oncology
targeted oncology
oncology
cancer
Рекомендации по теме
0:04:59
AML: Optimizing Selection and Use of Venetoclax + Azacitidine
0:58:13
Optimising transplant outcome in adults allografted for AML
0:29:13
Optimizing transplant outcomes in patients allografted for AML
0:11:35
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission ther...
1:00:26
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
1:00:26
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
1:00:26
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
1:00:26
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
0:08:16
Optimizing Frontline Therapy Selection and Follow-Up in CLL
1:01:31
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
1:01:31
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndr...
0:06:51
AML: Managing AEs With Venetoclax + Azacitidine
0:20:58
New Findings and Improved Outcomes in the Treatment of AML
0:10:08
Optimizing the Use of BCR-ABL TKIs in CML
0:52:20
Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0:54:08
Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights
0:08:28
Induction Chemotherapy for AML: Understanding the Patient Experience
1:05:36
Webinar: Optimizing AML Screening
0:20:19
Optimizing Early Clinical Investigations by Increasing Predictive Value of Non-Clinical Activities
0:09:37
How to optimize donor selection for allogeneic transplant?
0:01:54
Dr. Komrokji on Optimizing MDS Management
0:02:26
Magrolimab plus azacitidine in treatment-naïve AML
0:23:57
TwinStrand Biosciences discusses Duplex Sequencing I AACR 2019
0:58:32
Significance of Minimal Residual Disease in Acute Myeloid Leukemia
0:04:59
0:58:13
0:29:13
0:11:35
1:00:26
1:00:26
1:00:26
1:00:26
0:08:16
1:01:31
1:01:31
0:06:51
0:20:58
0:10:08
0:52:20
0:54:08
0:08:28
1:05:36
0:20:19
0:09:37
0:01:54
0:02:26
0:23:57
0:58:32